Farmak, a domestic leader of the pharmaceutical market, continues extending the portfolio of anti-inflammatory and anaesthetic products. Thus, a new product, Keywer, solution for injection 50 mg/ml 2 ml No 10 and tablets 25 mg No 10 is introduced to the market.
Keywer, solution for injection, is recommended for:
Keywer, tablets, is recommended for: